IP Library Patent Application 15543392
Patent Application
App. No. 15/543,392

Process Simulation in a Cell Processing Facility

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/543,392
Abstract

The present invention provides improved methods, facilities and systems for parallel processing of biological cellular samples in an efficient and scalable manner. The invention enables parallel processing of biological cellular samples, such as patient samples, in a space and time efficient fashion. Process simulation may be used to determine the optimal arrangement and/or quantity of cell processing equipment needed. The methods, facilities and systems of the invention find particular utility in processing patient samples for use in cell therapy.

Claims (11)

1 . A method for optimising the performance of a cell processing facility, said facility comprising plural cell processing units, and said facility providing processed cell samples for therapeutic use derived from cellular samples, the method comprising the steps of performing process simulation modelling on said cell processing facility to determine, at least, the optimal arrangement and/or number of processing units.

2 . The method of claim 1 , wherein each processing unit includes plural processing stations, and said modelling is used to optimise the number of processing stations at each unit for said optimal performance.

3 . The method of claim 1 , further comprising performing further process simulation modelling to determine the optimal operating staff numbers, and/or cell process equipment required.

4 . The method of claim 1 , further comprising performing further process simulation during operation of said facility, including analysis of current operating data and historic operating data in order to predict problematic operating conditions.

5 . The method of claim 1 , wherein said cell processing facility is used to process 50 or more, preferably 100 or more, more preferably 500 or more, more preferably 1000 or more, more preferably 5000 or more cellular samples per annum to provide said processed cell samples.

6 . The method of claim 1 wherein, said process modelling includes the step of determining the optimum ratio of operators and cell processing stations for a predetermined cell dose output.

7 . The method of claim 2 wherein said stations comprise at least cell isolation and concentration equipment and cell incubators, each employing uniquely identified cell containers or bags.

8 . A cell processing facility including: plural cell processing units operable to perform process steps on cellular samples derived from different patients in separate closed containers each having unique identification; a reader for reading and recording said identification at said units; wherein each unit includes one or plural processing stations which, if plural, are identical or similar within each unit; and wherein the or each unit is:

1) provided with a quantity of processing stations, the quantity being determined according to predetermined software steps to optimise the ratio of processing stations in each unit based on the desired output of the facility; and/or

2) operable according to predetermined software steps to optimise the use of the processing stations based on the desired output, and based on additional operating variables.

9 . Cells produced according to the methods defined in claim 1 , or produced by the cell processing facility of claim 8 , optionally, for use in autologous cell therapy.

Assignments (2)
CHANGE OF NAME Recorded Aug 31, 2020
From: GE HEALTHCARE BIO-SCIENCES CORP.
To: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Reel/Frame 053648/0854 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2017
From: BAKSH, DOLORES; SMITH, REGINALD DONOVAN; AKBAY, KUNTER SEREF; WOOD, NICHOLE LEA
To: GE HEALTHCARE BIO-SCIENCES CORP.
Reel/Frame 042999/0557 →